Editas Medicine, Inc. (EDIT) Social Stream



Editas Medicine, Inc. (EDIT): $11.12

-0.14 (-1.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add EDIT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

EDITAS MEDICINE INC (EDIT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering EDITAS MEDICINE INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 13 $80 $30 $54.909 $11.26 387.65%
2022-01-06 12 $80 $24 $52.2 $11.26 363.59%
2022-01-31 12 $80 $16 $51.4 $11.26 356.48%
2022-02-25 12 $80 $16 $46.4 $11.26 312.08%
2022-02-28 11 $80 $16 $41.777 $11.26 271.02%
2022-04-12 11 $80 $17 $41.888 $11.26 272.01%
2022-04-26 11 $80 $17 $41 $11.26 264.12%
2022-05-05 10 $80 $15 $37.333 $11.26 231.55%
2022-05-09 10 $80 $15 $37.111 $11.26 229.58%
2022-05-24 11 $80 $8 $34.2 $11.26 203.73%
2022-08-05 12 $80 $8 $30.1 $11.26 167.32%
2022-08-19 11 $80 $8 $30.444 $11.26 170.37%
2022-10-12 12 $80 $8 $29.2 $11.26 159.33%
2022-10-24 12 $80 $8 $27.818 $11.26 147.05%
2022-11-02 12 $80 $8 $27.545 $11.26 144.63%
2022-11-03 14 $80 $8 $25.666 $11.26 127.94%
2022-11-08 14 $80 $8 $25.25 $11.26 124.25%
2022-11-18 14 $43 $7 $20.083 $11.26 78.36%
2022-12-06 14 $35 $7 $16.166 $11.26 43.57%
2022-12-13 15 $35 $7 $15.769 $11.26 40.04%
2023-01-04 16 $36 $7 $16.642 $11.26 47.8%
2023-01-10 16 $36 $6 $16.571 $11.26 47.17%
2023-01-16 16 $36 $6 $15.142 $11.26 34.48%
2023-01-23 16 $36 $7 $15.214 $11.26 35.12%
2023-01-27 16 $36 $7 $15.142 $11.26 34.48%
2023-02-01 17 $36 $7 $15.133 $11.26 34.4%

The Trend in the Analyst Price Target


EDIT's average price target has moved down $15.31 over the prior 170 days.

EDIT reports an average of 116.52% for its upside potential over the past 49 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-28 12 80 16 41.777 17.12 144.02%
2022-05-05 10 80 15 37.333 14.56 156.41%
2022-05-09 11 80 15 37.111 11.11 234.03%
2022-08-05 12 80 8 30.100 19.42 54.99%
2022-12-13 15 35 7 15.769 9.96 58.32%

EDIT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.57 6 0 8 2 2 17

The Trend in the Broker Recommendations


Over the past 13 months, EDIT's average broker recommendation rating worsened by 0.09.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EDIT as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, EDITAS MEDICINE INC's variance in analysts' estimates is lower than -3368.73% of them.
  • In terms of how EDITAS MEDICINE INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 3253.42% of that group.
  • In terms of how EDITAS MEDICINE INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 2923.64% of that group.
  • In terms of how EDITAS MEDICINE INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 1464.35% of that group.

Stocks similar to EDITAS MEDICINE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RGNX, FATE, and IOVA.

Is EDIT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7619 seconds.